TY  - GEN
AU  - Sun,Jian
AU  - Xie,Qing
AU  - Tan,Deming
AU  - Ning,Qin
AU  - Niu,Junqi
AU  - Bai,Xuefan
AU  - Fan,Rong
AU  - Chen,Shijun
AU  - Cheng,Jun
AU  - Yu,Yanyan
AU  - Wang,Hao
AU  - Xu,Min
AU  - Shi,Guangfeng
AU  - Wan,Mobin
AU  - Chen,Xinyue
AU  - Tang,Hong
AU  - Sheng,Jifang
AU  - Dou,Xiaoguang
AU  - Shi,Junping
AU  - Ren,Hong
AU  - Wang,Maorong
AU  - Zhang,Hongfei
AU  - Gao,Zhiliang
AU  - Chen,Chengwei
AU  - Ma,Hong
AU  - Jia,Jidong
AU  - Hou,Jinlin
TI  - The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study
SN  - 1527-3350
PY  - 2014///0609
KW  - Adenine
KW  - adverse effects
KW  - Adolescent
KW  - Adult
KW  - Alanine Transaminase
KW  - blood
KW  - Antiviral Agents
KW  - China
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glomerular Filtration Rate
KW  - drug effects
KW  - Hepatitis B e Antigens
KW  - Hepatitis B, Chronic
KW  - Humans
KW  - Longitudinal Studies
KW  - Male
KW  - Middle Aged
KW  - Organophosphonates
KW  - Telbivudine
KW  - Thymidine
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.26885
ER  -